Global Gram-Negative Bacterial Infection Therapeutics Market Growth (Status and Outlook) 2025-2031
According to this study, the global Gram-Negative Bacterial Infection Therapeutics market size will reach US$ million by 2031.
Gram-negative bacteria generally refer to bacteria that show red in the gram-negative staining reaction.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Gram-Negative Bacterial Infection Therapeutics Industry Forecast” looks at past sales and reviews total world Gram-Negative Bacterial Infection Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Gram-Negative Bacterial Infection Therapeutics sales for 2025 through 2031. With Gram-Negative Bacterial Infection Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gram-Negative Bacterial Infection Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Gram-Negative Bacterial Infection Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gram-Negative Bacterial Infection Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gram-Negative Bacterial Infection Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gram-Negative Bacterial Infection Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gram-Negative Bacterial Infection Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Gram-Negative Bacterial Infection Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Gram-negative bacteria generally refer to bacteria that show red in the gram-negative staining reaction.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Gram-Negative Bacterial Infection Therapeutics Industry Forecast” looks at past sales and reviews total world Gram-Negative Bacterial Infection Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Gram-Negative Bacterial Infection Therapeutics sales for 2025 through 2031. With Gram-Negative Bacterial Infection Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gram-Negative Bacterial Infection Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Gram-Negative Bacterial Infection Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gram-Negative Bacterial Infection Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gram-Negative Bacterial Infection Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gram-Negative Bacterial Infection Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gram-Negative Bacterial Infection Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Gram-Negative Bacterial Infection Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Enteral Treatment
- Parenteral Treatment
- Topical Treatment
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Baxter
- Sanofi
- GlaxoSmithKline
- Novartis
- Pfizer
- Takeda
- Nektar Therapeutics
- Sumitomo
- Targeted Genetics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gram-Negative Bacterial Infection Therapeutics Market Size (2020-2031)
2.1.2 Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gram-Negative Bacterial Infection Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Gram-Negative Bacterial Infection Therapeutics Segment by Type
2.2.1 Enteral Treatment
2.2.2 Parenteral Treatment
2.2.3 Topical Treatment
2.3 Gram-Negative Bacterial Infection Therapeutics Market Size by Type
2.3.1 Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Gram-Negative Bacterial Infection Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Gram-Negative Bacterial Infection Therapeutics Market Size by Application
2.5.1 Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2020-2025)
3 GRAM-NEGATIVE BACTERIAL INFECTION THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Player
3.1.1 Global Gram-Negative Bacterial Infection Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Gram-Negative Bacterial Infection Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GRAM-NEGATIVE BACTERIAL INFECTION THERAPEUTICS BY REGION
4.1 Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2020-2025)
4.2 Global Gram-Negative Bacterial Infection Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gram-Negative Bacterial Infection Therapeutics Market Size Growth (2020-2025)
4.4 APAC Gram-Negative Bacterial Infection Therapeutics Market Size Growth (2020-2025)
4.5 Europe Gram-Negative Bacterial Infection Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2020-2025)
5.2 Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025)
5.3 Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2020-2025)
6.2 APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025)
6.3 APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2020-2025)
7.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025)
7.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GRAM-NEGATIVE BACTERIAL INFECTION THERAPEUTICS MARKET FORECAST
10.1 Global Gram-Negative Bacterial Infection Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Gram-Negative Bacterial Infection Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Gram-Negative Bacterial Infection Therapeutics Forecast
10.1.3 APAC Gram-Negative Bacterial Infection Therapeutics Forecast
10.1.4 Europe Gram-Negative Bacterial Infection Therapeutics Forecast
10.1.5 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Forecast
10.2 Americas Gram-Negative Bacterial Infection Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.2.2 Canada Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.2.3 Mexico Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.2.4 Brazil Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.3 APAC Gram-Negative Bacterial Infection Therapeutics Forecast by Region (2026-2031)
10.3.1 China Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.3.2 Japan Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.3.3 Korea Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.3.4 Southeast Asia Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.3.5 India Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.3.6 Australia Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.4 Europe Gram-Negative Bacterial Infection Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.4.2 France Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.4.3 UK Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.4.4 Italy Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.4.5 Russia Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.5 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.5.2 South Africa Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.5.3 Israel Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.5.4 Turkey Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.6 Global Gram-Negative Bacterial Infection Therapeutics Forecast by Type (2026-2031)
10.7 Global Gram-Negative Bacterial Infection Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gram-Negative Bacterial Infection Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Baxter
11.1.1 Baxter Company Information
11.1.2 Baxter Gram-Negative Bacterial Infection Therapeutics Product Offered
11.1.3 Baxter Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Baxter Main Business Overview
11.1.5 Baxter Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Gram-Negative Bacterial Infection Therapeutics Product Offered
11.2.3 Sanofi Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Product Offered
11.3.3 GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Gram-Negative Bacterial Infection Therapeutics Product Offered
11.4.3 Novartis Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Gram-Negative Bacterial Infection Therapeutics Product Offered
11.5.3 Pfizer Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Takeda
11.6.1 Takeda Company Information
11.6.2 Takeda Gram-Negative Bacterial Infection Therapeutics Product Offered
11.6.3 Takeda Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Takeda Main Business Overview
11.6.5 Takeda Latest Developments
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Company Information
11.7.2 Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Product Offered
11.7.3 Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Nektar Therapeutics Main Business Overview
11.7.5 Nektar Therapeutics Latest Developments
11.8 Sumitomo
11.8.1 Sumitomo Company Information
11.8.2 Sumitomo Gram-Negative Bacterial Infection Therapeutics Product Offered
11.8.3 Sumitomo Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sumitomo Main Business Overview
11.8.5 Sumitomo Latest Developments
11.9 Targeted Genetics
11.9.1 Targeted Genetics Company Information
11.9.2 Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Product Offered
11.9.3 Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Targeted Genetics Main Business Overview
11.9.5 Targeted Genetics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gram-Negative Bacterial Infection Therapeutics Market Size (2020-2031)
2.1.2 Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gram-Negative Bacterial Infection Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Gram-Negative Bacterial Infection Therapeutics Segment by Type
2.2.1 Enteral Treatment
2.2.2 Parenteral Treatment
2.2.3 Topical Treatment
2.3 Gram-Negative Bacterial Infection Therapeutics Market Size by Type
2.3.1 Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Gram-Negative Bacterial Infection Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Gram-Negative Bacterial Infection Therapeutics Market Size by Application
2.5.1 Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2020-2025)
3 GRAM-NEGATIVE BACTERIAL INFECTION THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Player
3.1.1 Global Gram-Negative Bacterial Infection Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Gram-Negative Bacterial Infection Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GRAM-NEGATIVE BACTERIAL INFECTION THERAPEUTICS BY REGION
4.1 Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2020-2025)
4.2 Global Gram-Negative Bacterial Infection Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gram-Negative Bacterial Infection Therapeutics Market Size Growth (2020-2025)
4.4 APAC Gram-Negative Bacterial Infection Therapeutics Market Size Growth (2020-2025)
4.5 Europe Gram-Negative Bacterial Infection Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2020-2025)
5.2 Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025)
5.3 Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2020-2025)
6.2 APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025)
6.3 APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2020-2025)
7.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025)
7.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GRAM-NEGATIVE BACTERIAL INFECTION THERAPEUTICS MARKET FORECAST
10.1 Global Gram-Negative Bacterial Infection Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Gram-Negative Bacterial Infection Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Gram-Negative Bacterial Infection Therapeutics Forecast
10.1.3 APAC Gram-Negative Bacterial Infection Therapeutics Forecast
10.1.4 Europe Gram-Negative Bacterial Infection Therapeutics Forecast
10.1.5 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Forecast
10.2 Americas Gram-Negative Bacterial Infection Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.2.2 Canada Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.2.3 Mexico Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.2.4 Brazil Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.3 APAC Gram-Negative Bacterial Infection Therapeutics Forecast by Region (2026-2031)
10.3.1 China Gram-Negative Bacterial Infection Therapeutics Market Forecast
10.3.2 Japan Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.3.3 Korea Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.3.4 Southeast Asia Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.3.5 India Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.3.6 Australia Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.4 Europe Gram-Negative Bacterial Infection Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.4.2 France Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.4.3 UK Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.4.4 Italy Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.4.5 Russia Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.5 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.5.2 South Africa Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.5.3 Israel Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.5.4 Turkey Market Gram-Negative Bacterial Infection Therapeutics Forecast
10.6 Global Gram-Negative Bacterial Infection Therapeutics Forecast by Type (2026-2031)
10.7 Global Gram-Negative Bacterial Infection Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gram-Negative Bacterial Infection Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Baxter
11.1.1 Baxter Company Information
11.1.2 Baxter Gram-Negative Bacterial Infection Therapeutics Product Offered
11.1.3 Baxter Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Baxter Main Business Overview
11.1.5 Baxter Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Gram-Negative Bacterial Infection Therapeutics Product Offered
11.2.3 Sanofi Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Product Offered
11.3.3 GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Gram-Negative Bacterial Infection Therapeutics Product Offered
11.4.3 Novartis Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Gram-Negative Bacterial Infection Therapeutics Product Offered
11.5.3 Pfizer Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Takeda
11.6.1 Takeda Company Information
11.6.2 Takeda Gram-Negative Bacterial Infection Therapeutics Product Offered
11.6.3 Takeda Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Takeda Main Business Overview
11.6.5 Takeda Latest Developments
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Company Information
11.7.2 Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Product Offered
11.7.3 Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Nektar Therapeutics Main Business Overview
11.7.5 Nektar Therapeutics Latest Developments
11.8 Sumitomo
11.8.1 Sumitomo Company Information
11.8.2 Sumitomo Gram-Negative Bacterial Infection Therapeutics Product Offered
11.8.3 Sumitomo Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sumitomo Main Business Overview
11.8.5 Sumitomo Latest Developments
11.9 Targeted Genetics
11.9.1 Targeted Genetics Company Information
11.9.2 Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Product Offered
11.9.3 Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Targeted Genetics Main Business Overview
11.9.5 Targeted Genetics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gram-Negative Bacterial Infection Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Enteral Treatment
Table 4. Major Players of Parenteral Treatment
Table 5. Major Players of Topical Treatment
Table 6. Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Gram-Negative Bacterial Infection Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. Gram-Negative Bacterial Infection Therapeutics Key Players Head office and Products Offered
Table 15. Gram-Negative Bacterial Infection Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Gram-Negative Bacterial Infection Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Gram-Negative Bacterial Infection Therapeutics
Table 40. Key Market Challenges & Risks of Gram-Negative Bacterial Infection Therapeutics
Table 41. Key Industry Trends of Gram-Negative Bacterial Infection Therapeutics
Table 42. Global Gram-Negative Bacterial Infection Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Gram-Negative Bacterial Infection Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Gram-Negative Bacterial Infection Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Baxter Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 47. Baxter Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 48. Baxter Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Baxter Main Business
Table 50. Baxter Latest Developments
Table 51. Sanofi Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 52. Sanofi Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 53. Sanofi Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Sanofi Main Business
Table 55. Sanofi Latest Developments
Table 56. GlaxoSmithKline Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 57. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 58. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. GlaxoSmithKline Main Business
Table 60. GlaxoSmithKline Latest Developments
Table 61. Novartis Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 62. Novartis Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 63. Novartis Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Novartis Main Business
Table 65. Novartis Latest Developments
Table 66. Pfizer Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 67. Pfizer Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 68. Pfizer Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Pfizer Main Business
Table 70. Pfizer Latest Developments
Table 71. Takeda Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 72. Takeda Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 73. Takeda Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Takeda Main Business
Table 75. Takeda Latest Developments
Table 76. Nektar Therapeutics Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 77. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 78. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Nektar Therapeutics Main Business
Table 80. Nektar Therapeutics Latest Developments
Table 81. Sumitomo Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 82. Sumitomo Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 83. Sumitomo Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Sumitomo Main Business
Table 85. Sumitomo Latest Developments
Table 86. Targeted Genetics Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 87. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 88. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Targeted Genetics Main Business
Table 90. Targeted Genetics Latest Developments
Table 1. Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gram-Negative Bacterial Infection Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Enteral Treatment
Table 4. Major Players of Parenteral Treatment
Table 5. Major Players of Topical Treatment
Table 6. Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2020-2025)
Table 9. Gram-Negative Bacterial Infection Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2020-2025)
Table 12. Global Gram-Negative Bacterial Infection Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Player (2020-2025)
Table 14. Gram-Negative Bacterial Infection Therapeutics Key Players Head office and Products Offered
Table 15. Gram-Negative Bacterial Infection Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Region (2020-2025)
Table 20. Global Gram-Negative Bacterial Infection Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Country (2020-2025)
Table 24. Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2020-2025)
Table 26. Americas Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2020-2025)
Table 28. APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Region (2020-2025)
Table 30. APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Country (2020-2025)
Table 34. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Gram-Negative Bacterial Infection Therapeutics
Table 40. Key Market Challenges & Risks of Gram-Negative Bacterial Infection Therapeutics
Table 41. Key Industry Trends of Gram-Negative Bacterial Infection Therapeutics
Table 42. Global Gram-Negative Bacterial Infection Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Gram-Negative Bacterial Infection Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Gram-Negative Bacterial Infection Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Baxter Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 47. Baxter Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 48. Baxter Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Baxter Main Business
Table 50. Baxter Latest Developments
Table 51. Sanofi Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 52. Sanofi Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 53. Sanofi Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Sanofi Main Business
Table 55. Sanofi Latest Developments
Table 56. GlaxoSmithKline Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 57. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 58. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. GlaxoSmithKline Main Business
Table 60. GlaxoSmithKline Latest Developments
Table 61. Novartis Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 62. Novartis Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 63. Novartis Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Novartis Main Business
Table 65. Novartis Latest Developments
Table 66. Pfizer Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 67. Pfizer Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 68. Pfizer Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Pfizer Main Business
Table 70. Pfizer Latest Developments
Table 71. Takeda Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 72. Takeda Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 73. Takeda Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Takeda Main Business
Table 75. Takeda Latest Developments
Table 76. Nektar Therapeutics Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 77. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 78. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Nektar Therapeutics Main Business
Table 80. Nektar Therapeutics Latest Developments
Table 81. Sumitomo Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 82. Sumitomo Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 83. Sumitomo Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Sumitomo Main Business
Table 85. Sumitomo Latest Developments
Table 86. Targeted Genetics Details, Company Type, Gram-Negative Bacterial Infection Therapeutics Area Served and Its Competitors
Table 87. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Product Offered
Table 88. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Targeted Genetics Main Business
Table 90. Targeted Genetics Latest Developments
LIST OF FIGURES
Figure 1. Gram-Negative Bacterial Infection Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gram-Negative Bacterial Infection Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gram-Negative Bacterial Infection Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Gram-Negative Bacterial Infection Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type in 2024
Figure 10. Gram-Negative Bacterial Infection Therapeutics in Hospitals
Figure 11. Global Gram-Negative Bacterial Infection Therapeutics Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Gram-Negative Bacterial Infection Therapeutics in Clinics
Figure 13. Global Gram-Negative Bacterial Infection Therapeutics Market: Clinics (2020-2025) & ($ millions)
Figure 14. Gram-Negative Bacterial Infection Therapeutics in Others
Figure 15. Global Gram-Negative Bacterial Infection Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Gram-Negative Bacterial Infection Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Gram-Negative Bacterial Infection Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Gram-Negative Bacterial Infection Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Gram-Negative Bacterial Infection Therapeutics Value Market Share by Country in 2024
Figure 24. United States Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 1. Gram-Negative Bacterial Infection Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gram-Negative Bacterial Infection Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gram-Negative Bacterial Infection Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Gram-Negative Bacterial Infection Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type in 2024
Figure 10. Gram-Negative Bacterial Infection Therapeutics in Hospitals
Figure 11. Global Gram-Negative Bacterial Infection Therapeutics Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Gram-Negative Bacterial Infection Therapeutics in Clinics
Figure 13. Global Gram-Negative Bacterial Infection Therapeutics Market: Clinics (2020-2025) & ($ millions)
Figure 14. Gram-Negative Bacterial Infection Therapeutics in Others
Figure 15. Global Gram-Negative Bacterial Infection Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Gram-Negative Bacterial Infection Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Gram-Negative Bacterial Infection Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Gram-Negative Bacterial Infection Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Gram-Negative Bacterial Infection Therapeutics Value Market Share by Country in 2024
Figure 24. United States Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Gram-Negative Bacterial Infection Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Gram-Negative Bacterial Infection Therapeutics Market Size 2026-2031 ($ millions)
More Publications
Gram-Negative Bacterial Infections Ongoing Global Clinical Trials Analysis and Outlook
US$ 630.00
June 2018
238 pages
Gram-Negative Bacterial Infections: Pipeline Intelligence, 2019
US$ 1,200.00
December 2018
60 pages
